Wolff, whose current role is director of Patient Advocacy and Medical Science Liaison at Santhera Pharmaceuticals (USA) Inc, was nominated by the UMDF to represent Santhera as a member of the IAC due to her expertise and advocacy work for patients with mitochondrial disease.
On the IAC, Wolff will become part of a broad stakeholder community which works to foster value-added industry collaboration as well as drive key UMDF initiatives.
Wolff stated: "I am thrilled to be a part of the UMDF Industry Advisory Council and to continue Santhera's leadership in the field of mitochondrial disease.
26, 2010) [hereinafter UMDF, Mitochondrial Disease].
34) See UMDF, Mitochondrial Disease, supra note 27.
UMDF Science and Alliance Officer, Philip Yeske, Ph.
The UMDF is committed to the long-term financial sponsorship of the MDCR and will serve as guardian of the information and coordinator of the project.
You can help by spreading the word about mitochondrial disease and the UMDF
(for more information, see Resource Organizations).